Food and Drug Administration

Biological Response Modifiers Advisory Committee

March 18, 2004


Cellular Products for Cardiac Diseases, Dr. Dwaine Rieves, MD, DA (HTM) (PPT)

Cellular Therapies for Cardiac Diseases - FDA Preclinical Perspective, Dr. Richard McFarland, PhD, MD, FDA (HTM) (PPT)

Cardiac Catheters for Delivery of Cell Suspensions, Dr. Donald Jensen, DVM, MS, FDA (HTM) (PPT)

Transcatheter Myocardial Cell Delivery: Questions & Considerations From the Trenches, Dr. Robert Lederman, MD, NIH (HTM) (PPT)